Skip to main content
Top
Published in: Arthritis Research & Therapy 1/1999

01-12-2000 | Web Report

The North American Rheumatoid Arthritis Consortium

Author: S Louis Bridges

Published in: Arthritis Research & Therapy | Issue 1/1999

Login to get access

Excerpt

The North American Rheumatoid Arthritis Consortium (NARAC) is a group of ten research sites located across the United States, cooperating to conduct research on the genetics of rheumatoid arthritis. The initial goal is to identify 1000 families in which two or more siblings are affected with rheumatoid arthritis. Detailed clinical information, hand radiographs, serum, and peripheral blood DNA will be obtained from each affected sibling. This database and serum and DNA repository, which is sponsored by the National Institutes of Health and the Arthritis Foundation, will form a resource for the entire scientific community to allow for a comprehensive analysis of genetic susceptibility to rheumatoid arthritis. Criteria for enrollment include the following: 1) two or more siblings with rheumatoid arthritis by American College of Rheumatology criteria, 2) at least one sibling with documented erosions on hand radiographs and 3) one of the two siblings with onset of disease between the ages of 18 and 60. …
Metadata
Title
The North American Rheumatoid Arthritis Consortium
Author
S Louis Bridges
Publication date
01-12-2000
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/1999
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar-2000-2-webreport0012

Other articles of this Issue 1/1999

Arthritis Research & Therapy 1/1999 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.